Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer

Autor: Akin Telli, Tugba, Bregni, Giacomo, Vanhooren, Michele, Saude Conde, Rita, Hendlisz, Alain, Sclafani, Francesco
Zdroj: In Cancer Treatment Reviews November 2022 110
Databáze: ScienceDirect